About this trial
This study aims to evaluate the effect of intraoperative dexamethasone on early postoperative sleep quality in adult patients undergoing nasal surgery under general anesthesia.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adults aged 19 years or older undergoing nasal surgery.
Disqualifiers
Patients who do not provide informed consent
Patients with neurological disease or cognitive impairment that may interfere with questionnaire completion
Patients with pre-existing sleep disorders or those taking sleep medications
Patients receiving chronic corticosteroid therapy
Trial design
Parallel
Treatments tested in this trial
Dexamethasone
DrugDexamethasone 10 mg will be administered intravenously during induction of general anesthesia. This single-dose corticosteroid is used for its anti-inflammatory and antiemetic effects. All other perioperative management will be conducted according to standard institutional protocols and will be identical to the control group
Normal Saline
Drugnormal saline 2cc will be administered intravenously during induction of general anesthesia.
Treatment groups
Trial outcomes
Primary outcomes
Richards-Campbell Sleep Questionnaire (RCSQ) score
Sleep quality will be assessed using the Richards-Campbell Sleep Questionnaire (RCSQ), a validated patient-reported outcome measure. The RCSQ consists of five items evaluating depth of sleep, sleep latency, number of awakenings, efficiency of sleep, and overall sleep quality. Each item is scored on a visual analog scale from 0 to 100, with higher scores indicating better sleep quality.
Secondary outcomes
Quality of Recovery-15 (QoR-15) score
Overall postoperative recovery will be assessed using the Quality of Recovery-15 (QoR-15) questionnaire, a validated patient-reported outcome measure. Higher scores indicate better recovery. The total score ranges from 0 to 150, with higher scores indicating better recovery.
sleep efficiency
sleep efficiency (%) during the postoperative night (day of surgery), measured using a wearable device.
Incidence of postoperative nausea and vomiting
Incidence and severity of postoperative nausea and vomiting assessed using a 4-point scale, and use of rescue antiemetics. 0 = no nausea or vomiting, 1. = mild nausea, 2. = moderate nausea, 3. = severe nausea or vomiting. Higher scores indicate worse symptoms.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: